EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN

Fadi Fakhouri, Andrew S Bomback, Gema Ariceta, Yahsou Delmas, Bradley P Dixon iD, Daniel P Gale iD, Larry A Greenbaum, Seung Hyeok Han, Nicole Isbel, Moglie Le Quintrec, Christoph Licht, Antonio Mastrangelo und 19 weitere

New England Journal of Medicine · 04.12.2025 · 393 (22) · 2210-2220

DOI: 10.1056/nejmoa2501510 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift New England Journal of Medicine, erschienen am 04.12.2025. Verfasst von Fadi Fakhouri und 30 weiteren Autor:innen. Beteiligte Einrichtung: Lausanne University Hospital, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Complement C3, Glomerulonephritis, Membranoproliferative, Proteinuria, Peptides, Cyclic. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Swedish Orphan Biovitrum, Apellis Pharmaceuticals.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement C3Glomerulonephritis, MembranoproliferativeProteinuriaPeptides, CyclicAdolescentAdultFemaleHumansMaleMiddle AgedYoung AdultCreatinineDouble-Blind MethodKidney GlomerulusTreatment Outcome

Substanzen

Complement C3CreatininepegcetacoplanPeptides, Cyclic

Autor:innen und Institutionen

  • Lausanne University Hospital, Lausanne, Switzerland.
  • University of Lausanne, Lausanne, Switzerland.
  • Columbia University Irving Medical Center, New York.
  • Hospital Vall d'Hebron, Barcelona.
  • Bordeaux University Hospital, Bordeaux, France.
  • University of Colorado School of Medicine, Aurora.

ORCID-Profile: Bradley P Dixon, Daniel P Gale, Giuseppe Remuzzi

Förderung

  • Swedish Orphan Biovitrum
  • Apellis Pharmaceuticals

Zitieren

APA

Fakhouri, F., Bomback, A. S., Ariceta, G., Delmas, Y., Dixon, B. P., Gale, D. P., Greenbaum, L. A., Han, S. H., Isbel, N., Le Quintrec, M., Licht, C., Mastrangelo, A., Mizuno, M., Neves de Holanda, M. I., Pickering, M. C., Remuzzi, G., Van De Kar, N., Vivarelli, M., Walker, P. D., …, & VALIANT Trial Investigators Group (2025). Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. New England Journal of Medicine, 393(22), 2210-2220. https://doi.org/10.1056/nejmoa2501510

Vancouver

Fakhouri F, Bomback AS, Ariceta G, Delmas Y, Dixon BP, Gale DP, et al. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. New England Journal of Medicine. 2025;393(22):2210-2220. doi:10.1056/nejmoa2501510

BibTeX
@article{Fakhouri2025,
  author = {Fakhouri, Fadi and Bomback, Andrew S and Ariceta, Gema and Delmas, Yahsou and Dixon, Bradley P and Gale, Daniel P and Greenbaum, Larry A and Han, Seung Hyeok and Isbel, Nicole and Le Quintrec, Moglie and Licht, Christoph and Mastrangelo, Antonio and Mizuno, Masashi and Neves de Holanda, Maria Izabel and Pickering, Matthew C and Remuzzi, Giuseppe and Van De Kar, Nicole and Vivarelli, Marina and Walker, Patrick D and Wallace, Dean and Zecher, Daniel and Francois, Cedric and Deschatelets, Pascal and Li, Li and Wang, Zhongshen and Abad-Franch, Lydia and Kinnman, Nils and López-Lázaro, Luis and Szamosi, Johan and Nester, Carla M and VALIANT Trial Investigators Group, VALIANT Trial Investigators Group},
  title = {Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN},
  journal = {New England Journal of Medicine},
  year = {2025},
  volume = {393},
  number = {22},
  pages = {2210--2220},
  doi = {10.1056/nejmoa2501510}
}
Kostenlos starten →